home page

Pipeline

NeurAxon Pharma Inc has a pipeline of clinical and preclinical New Chemical Entities (NCEs) as clinical leads, back-ups and new developments. Characteristic profiles and properties: Biopharmaceutics Classification System (BCS) 1, low Cost of Goods, API stability up to 3 years, 90 day primate toxicology with minimal findings and safety in elderly patients.

Pipeline


CoM composition of matter patent; others possible


Home | NeurAxon | Market | Pipeline | Research | News | Contact